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Abstract Chest physiotherapy (CP) using passive expira-
tory manoeuvres is widely used in Western Europe for the
treatment of bronchiolitis, despite lacking evidence for its
efficacy. We undertook an open randomised trial to evaluate
the effectiveness of CP in infants hospitalised for bron-
chiolitis by comparing the time to clinical stability, the daily
improvement of a severity score and the occurrence of
complications between patients with and without CP.
Children <1 year admitted for bronchiolitis in a tertiary
hospital during two consecutive respiratory syncytial virus
seasons were randomised to group 1 with CP (prolonged
slow expiratory technique, slow accelerated expiratory
flow, rarely induced cough) or group 2 without CP. All
children received standard care (rhinopharyngeal suction-
ing, minimal handling, oxygen for saturation ≥92%,
fractionated meals). Ninety-nine eligible children (mean
age, 3.9 months), 50 in group 1 and 49 in group 2, with
similar baseline variables and clinical severity at admission.
Time to clinical stability, assessed as primary outcome, was
similar for both groups (2.9±2.1 vs. 3.2±2.8 days, P=
0.45). The rate of improvement of a clinical and respiratory
score, defined as secondary outcome, only showed a slightly
faster improvement of the respiratory score in the intervention
group when including stethoacoustic properties (P=0.044).
Complications were rare but occurred more frequently,
although not significantly (P=0.21), in the control arm. In
conclusion, this study shows the absence of effectiveness of
CP using passive expiratory techniques in infants hospital-
ised for bronchiolitis. It seems justified to recommend
against the routine use of CP in these patients.
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Introduction
Viral bronchiolitis is usually a mild and self-limited disease
[23], for which no pharmacological strategy was yet shown
to be effective in reducing the length of hospital stay or the
severity and duration of symptoms [4, 15, 26]. Consequent-
ly, the actual clinical practice guidelines consist of general
supportive care, including minimal handling, nasal washings,
oxygen and fluid replacement therapy when appropriate and
sometimes bronchodilators [22, 25]. Similarly, current inter-
national recommendations do not advocate the routine
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prescription of chest physiotherapy (CP) [3, 22, 25] partly
because CP lacks scientifically proven clinical benefits and
because it may cause complications such as rib fractures [5, 6]
or worsening dyspnoea and hypoxaemia [28]. A recent
updated Cochrane Review on the efficacy of “conventional
chest physiotherapy” (cCPT), mainly vibration, percussion
and postural drainage, in infants with acute bronchiolitis
found no reduction in the length of hospital stay, oxygen
requirements or clinical severity in the intervention group
[19]. Nonetheless, other “new” techniques using passive
expiratory manoeuvres to allow the mobilisation of secre-
tions without airway collapse are nowadays routinely used in
some regions of Europe [20] and were part of the French
2001 national consensus statement for the management of
bronchiolitis in infants [24]. Only recently, the use of chest
physiotherapy with passive expiratory techniques has been
challenged and studied in bronchiolitis [10]. However, there
is a lack of randomised studies addressing an evidence-based
answer to this question.
The primary objective of this open randomised trial was
to evaluate the effectiveness of CP techniques using passive
acceleration of expiratory flux in reducing the time to
clinical stability in infants admitted for acute bronchiolitis
compared to infants not receiving CP. We also assessed the
impact of CP on the daily improvement of a validated
clinical and respiratory severity score and the occurrence of
complications.
Materials and methods
Study population
Patients were recruited among children ≤1 year old
admitted with the diagnosis of bronchiolitis during two
consecutive respiratory syncytial virus (RSV) seasons
(2005–2006 and 2006–2007). The start and the end of the
RSV season were defined when ≥2 admissions were due to
RSV infection during two consecutive 7-day periods and
when ≤1 such admission occurred during two consecutive
7-day periods, respectively [11, 14]. Patients with comor-
bidities such as cystic fibrosis, neuromuscular disease or
congenital heart disease, or patients admitted directly to the
intensive care unit, were excluded from the study.
Patients were recruited by the participating physiothera-
pists (PL, CO, MB, HS, MF-B) or by the study physician
(IR). Informed, signed consent was obtained from at least
one parent. Randomisation was done by the attribution of a
number contained in a sealed opaque envelope opened
following the inclusion consent. Envelopes were prepared
according to a randomisation list in blocks of random
length (8, 10 or 12) by the study epidemiologist, not
involved in the clinical phase of the study (TP).
Study design
This was a monocentric, open, randomised trial in infants
hospitalised with bronchiolitis comparing the effectiveness
of CP vs. no physiotherapy, in addition to the standard care
for bronchiolitis. Our institution is not only a tertiary centre
but also a primary care hospital as it is the only paediatric
facility in the state of Geneva. This study was approved by
the institution’s ethical committee on clinical research in
children (protocol 05-210).
Standards of care
All infants were treated according to the national and
international recommendations for the care of infants
hospitalised with bronchiolitis [22, 25]. Rhinopharyngeal
suctioning after instillation of normal saline solution was
applied to all patients if needed, as well as minimal
handling, oxygen to achieve a saturation (SpO2) ≥92%
and fractionated meals. Topical bronchodilators and ste-
roids were not routinely used as they are not recommended
in Switzerland. Nasal drops such as xylometazoline were
often employed to decrease nasal congestion. Finally,
antibiotics were administered when concomitant bacterial
infection was suspected (prolonged fever, otitis media and
increased white cell count).
All children underwent daily clinical evaluations at a
fixed time point prior to the physiotherapy sessions when
allocated to the group with CP. Evaluations were performed
by a study physiotherapist who was different from the
physiotherapist administering the treatment. Interobserver
agreement among the five study physiotherapists for the
evaluation score was excellent (kappa=1.0).
Experimental intervention (chest physiotherapy)
Patients assigned to the intervention group had two daily
physiotherapy sessions provided by a physiotherapist not
participating in the study at least 2 h after feeds to avoid
abdominal discomfort. The following techniques were used
[1, 8, 20, 24]:
– Prolonged slow expiratory technique (PSET) obtained
by bimanual pressure over the thoracic cage and the
abdomen, exerted at the start of the expiratory phase
down to the residual volume and maintained for two to
three respiratory cycles. This technique allows com-
plete expiration in the presence of bronchial obstruction
and facilitates drainage of the distal airways.
– Slow accelerated expiratory flow obtained by a manual
pressure of variable strength, speed and length exerted
over the thoracic cage at different lung volumes to
optimise bronchial clearance of the proximal airways
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– Induced cough achieved after a brief manual pressure
over the trachea at the level of the suprasternal notch at
the end of the inspiration (rarely used)
Outcome variables
Primary outcome
– Time to clinical stability, defined by feeding more than
50% of the required amount, the absence of vomiting,
undisrupted sleep and SpO2 ≥92% for more than 10 h
Secondary outcome
– Change in clinical state, measured by a general score
made of three well-being items (feeding, vomiting and
quality of sleep)
– Change in respiratory state, measured by a respiratory
score made of seven items (respiratory rate, SpO2,
presence and severity of retractions, adventitious respi-
ratory sounds, presence of vesicular murmur, thoracic
distension)
These scores, derived from existing literature [7, 9,
13, 27], correlate significantly, are strongly associated
with the severity of disease and the number of days to
clinical stabilisation (see on line section Table 1 and Fig. 1)
and have high inter-rater reproducibility (kappa=1.0).
– Occurrence of complications
Statistics
We first compared the groups at baseline for demographic
and clinical characteristics. Categorical and continuous
variables were compared between the groups. Dichotomous
outcome variables were compared using Fisher’s exact
tests. Time to clinical stability was compared using
Kaplan–Meier curves and the logrank test. This variable
was also compared using a Student’s t test. The level of
significance for the tests was set at 0.05. The study was
designed to detect a difference of a half standard deviation
in time to clinical stability (estimated SD was 2 days based
on previous hospitalisations, difference to be detected
1 day), with power of 90% and type one error of 5%. The
calculated sample size was 80 patients in each arm.
Changes in variables that were measured on a daily basis
(general and respiratory score, SpO2, respiratory rate) were
examined in mixed linear models where daily observations
were nested within patients. The model included the
treatment group, the day of hospitalisation and an interac-
tion term of treatment by day as fixed predictors. It
included a patient-specific intercept and slope as random
predictors. The treatment by day interaction captures the
benefit of physiotherapy vs. control group in unit improve-
ment per day. Analyses were performed using SPSS 17
software.
Results
Demographic data
A total of 103 children were randomised, 64 during the
first winter season and 39 during the second season.
Unfortunately, the second RSV season was very mild.
Four children (one in the CP group and three in the
control group) were subsequently excluded due to
parental withdrawal of consent, erroneous initial diag-
nosis and direct admission to the intensive care unit or
age (14 months). The 99 eligible children were evenly
distributed between the CP arm (50) and the control
arm (49).
The two groups were comparable at baseline, and there
was no difference in clinical severity at admission as
demonstrated by the initial clinical and respiratory score
(Table 1). The administration of nebulised bronchodilators
was similar between groups (38.0% vs. 40.8%, P=0.84) as
was the proportion of children receiving nasal decongestant
or oral antibiotics (64.0% vs. 69.4%, P=0.67 and 20.0% vs.
20.3%, P=1).
Clinical evolution
Primary outcome assessed by time to clinical stability
(eating more than 50% of the required amount, the absence
of vomiting, undisrupted sleep and SpO2 ≥92% for more
than 10 h) did not differ significantly between the CP and
the control group (2.9±2.1 days vs. 3.2±2.8 days, P=0.45;
Fig. 1). Secondary outcomes, assessed by daily changes in
clinical score (feeding, vomiting, sleep), in SpO2 and in
respiratory rate, were identical in the two groups. However,
there was a slightly faster improvement reaching statistical
significance for the daily changes in the respiratory score in
the CP group (Table 2).
Occurrence of complications
Complications were defined as concomitant bacterial infec-
tion or transfer to the intensive care unit due to respiratory
fatigue. Rescue CP was allowed in case of hypercapnia or
need for nasal continuous positive airway pressure. Compli-
cations related to bronchiolitis severity were rare (n=19,
18%), but tended to occur more frequently in the control
group without reaching statistical significance (12 vs. 7, P=
0.21). No direct complications of CP such as respiratory
deterioration occurred.
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Discussion
This open randomised study assesses the efficacy of CP using
passive expiratory techniques for the care of infants hospital-
ised for bronchiolitis. It does not show significant clinical
benefits of daily CP compared to no CP in addition to simple
rhinopharyngeal suctioning. In particular, the primary outcome
of time to clinical stability was not significantly different
between the groups. Of the secondary outcomes, analysed
separately in order to better distinguish the impact of CP on
respiratory items and general items, neither the respiratory rate
nor the SpO2 improved more rapidly in the CP group, but the
daily changes of the respiratory score were slightly faster
though the difference was not major in clinical terms.
In diseases with impaired mucociliary clearance such as
cystic fibrosis, CP has been shown to improve bronchial
mucus transport [12]. In viral bronchiolitis, characterised by
inflammation, oedema and necrosis of epithelial cells lining
small airways and increased mucus production, CP could
theoretically be efficacious in helping the clearance of
airway secretions. However, studies using cCPT (vibration
and percussion with postural drainage) have not shown any
benefit on the severity of the clinical score, including
oxygen requirements and length of hospital stay, in patients
receiving cCPT compared to controls [19]. In French-
speaking Europe, these techniques have largely been
replaced by ones using passive expiratory manoeuvres such
as PSET [1, 8, 20]. These techniques avoid a high
transmural pressure and allow the mobilisation of secretions
from the more distal airways [17]. Despite its widespread
use, only one study published in an abstract form showed a
statistically significant decrease in severity score, SpO2 and
heart rate after physiotherapy using PSET and induced
cough [21]. Conversely, our work did not show a
significantly faster improvement in the severity score
assessed through general well-being items such as feeding,
vomiting or sleep in the group with CP or in the respiratory
rate and SpO2 evaluated separately. There was however a
slightly significant decrement in the respiratory score
composed of all items (presence and severity of retractions,
auscultation, hyperinflation, respiratory rate and SpO2) that
we explain by the change in adventitious sounds following
a CP session due to the displacement of secretions. Most of
all, our study using passive expiratory techniques did not
reduce the time to clinical stability, defined by feeding more
than 50% of the required amount, the absence of vomiting,
undisrupted sleep and SpO2 ≥92% for more than 10 h in the
intervention group. Likewise, a multicentre, randomised
Table 1 Demographic and
clinical severity data
Results are expressed as n/n for
sex, mean (SD) and n/N (%)
RSV respiratory syncytial virus,
NPS nasopharyngeal swabs
Physiotherapy
group (N=50)
Control group
(N=49)
Sex M/F 27/23 28/21
Age in days, means (SD) 110 (95) 108 (86)
First episode of bronchiolitis 37/50 (74.0) 42/49 (87.5)
History of eczema 4/50 (8.3) 3/49 (6.1)
RSV ELISA positive (NPS) 37/50 (74.0) 37/49 (75.5)
ELISA positive for other viruses 1/50 (2.0) 1/49 (2.0)
Means (SD)
Clinical score 0.73 (0.91) 0.73 (0.96)
Respiratory score 9.5 (3.6) 9.1 (3.6)
Respiratory rate 53.2 (12.7) 51.2 (11.3)
Oxygen saturation (SpO2) 91.9 (4.5) 92.4 (4.8)
Capillary blood pH 7.37 (0.06) 7.37 (0.05)
Capillary pCO2 (kPa) 5.73 (1.72) 6.11 (1.30)
Bicarbonates (mmol/l) 23.1 (2.5) 24.3 (2.1)
Table 2 Daily changes (unit
per day) in outcome indicators
using mixed linear models
(95% confidence interval)
Physiotherapy group Control group P
Clinical score (points/day) −0.12 (−0.08 to −0.15) −0.09 (−0.06 to −0.13) 0.37
Respiratory score (points/day) −1.6 (−1.4 to −1.8) −1.3 (−1.1 to −1.5) 0.044
Oxygen saturation (%/day) 1.0 (0.7 to 1.2) 1.0 (0.8 to 1.2) 0.85
Respiratory rate (rate/day) −1.1 (−0.6 to −1.7) −0.7 (−0.2 to −1.2) 0.24
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trial conducted in France [10] found no significant effect of
CP on time to recovery, defined by a shorter time without
oxygen supplementation, the absence of chest recession and
adequate feeding, in the intervention group. Both these
randomised trials seem to confirm that interventions such as
CP do not accelerate the natural evolution of bronchiolitis, a
self-limited disease in the majority of cases. Thus, conclusions
derived from percussion and vibration techniques [2, 16, 19,
28] can also be applied to techniques using passive accelera-
tion of expiratory flux mainly because the inflammatory
response has the greatest impact on severity of bronchiolitis
and cannot be relieved by physical measures [18, 22, 23].
Interestingly, patients in the physiotherapy group tended to
have fewer complications even if they occurred less frequently
than generally described [29]. This difference cannot be
attributed to a higher initial severity of disease and is difficult
to explain. We cannot exclude that in cases with a severe
course, CP might delay or prevent the need for supportive
ventilation. However, the number of complications of
bronchiolitis was scarce and could not be analysed separate-
ly. Contrarily to the study from Gajdos et al. [10], where they
experienced an increased proportion of respiratory destabili-
zation or vomiting in children during CP procedure, we did not
observe direct complications of CP. This might be explained
by our strict timing of CP sessions long after feeding.
The lack of blinding of this open study was overcome by
separating the evaluations and the interventions. One physio-
therapist carried out the clinical evaluation at a fixed time
point prior to the physiotherapy sessions in the CP group, and
another physiotherapist performed the daily treatments.
It is important to recall that only hospitalised patients
were recruited, representing a minority of children with
bronchiolitis. Thus, our observations cannot be extended to
outpatients without further work.
In conclusion, this study shows the absence of effective-
ness of CP techniques using passive acceleration of expiratory
flux in infants hospitalised for bronchiolitis. It seems justified
to recommend against the routine prescription of CP, as
already proposed by some consensus conferences [25]. This
important finding should be included when establishing
allocation of resources in the actual cost-containment era.
Further work is needed before extending this recommenda-
tion to children managed on an outpatient basis.
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